United Therapeutics Corporation (UTHR)
United Therapeutics Corporation (UTHR)
$81.31 USD
Updated Aug 20 4:00pm
Add UTHR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
UTHR Stock Chart More Charts
UTHR Price/Volume Stats
| Current price | $81.31 |
| Prev. close | $81.82 |
| Day low | $80.69 |
| Day high | $82.48 |
| 50-day MA | $78.88 |
| 200-day MA | $101.61 |
| 52-week high | $129.59 |
| 52-week low | $74.31 |
| Volume | 245,398 |
| Avg. volume | 553,152 |
| Dividend yield | N/A |
| Market Cap | 3.57B |
United Therapeutics Corporation (UTHR) Company Bio
United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.
Top Stories View All
Best & Worst Performing Stock Industries for August 20, 2019
Best & Worst Performing Small Cap Stocks for August 20, 2019
Best & Worst Performing Mid Cap Stocks for August 20, 2019
Best & Worst Performing Mega Cap Stocks for August 20, 2019
Best & Worst Performing Large Cap Stocks for August 20, 2019
View All Top Stories
Loading social stream, please wait...